Skip to main content
SpringerLink
Log in

Canavan’s spongiform leukodystrophy

A clinical anatomy of a genetic metabolic CNS disease

  • Review Article
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Canavan disease (CD) is a globally distributed early-onset leukodystrophy. It is genetic in nature, and results from an autosomally inherited recessive trait that is characterized by loss of the axon’s myelin sheath while leaving the axons intact, and spongiform degeneration especially in white matter. There is also a buildup of N-acetyl-l-aspartate (NAA) in brain, as well as NAA acidemia and NAA aciduria. The cause of the altered NAA metabolism has been traced to several mutations in the gene for the production of aspartoacylase, located on chromosome 17, which is the primary enzyme involved in the catabolic metabolism of NAA. In this review, an attempt is made to correlate the change in NAA metabolism that results from the genetic defects in CD with the processes involved in the development of the CD syndrome. In addition, present efforts to counter the results of the genetic defects in this disease are also considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adachi M. and Volk B. W. (1968) Protracted form of spongy degeneration of the central nervous system. Neurology 18, 1084–1092.

    PubMed  CAS  Google Scholar 

  • Adornato B. T., O’Brien J. S., Lampert P. W., Roe T. F. and Neustein H. B. (1972) Cerebral spongy degeneration of infancy. A biochemical and ultrastructural study of affected twins. Neurology 22, 202–210.

    PubMed  CAS  Google Scholar 

  • Baslow M. H. (1999a) The existence of molecular water pumps in the nervous system. A review of the evidence. Neurochem. Int. 34, 77–90.

    Article  PubMed  CAS  Google Scholar 

  • Baslow M. H. (1999b) Molecular water pumps and the etiology of Canavan disease; a case of the sorcerer’s apprentice. J. Inherit. Metabol. Dis. 22, 99–101.

    Article  CAS  Google Scholar 

  • Baslow M. H. (2000) Functions of N-acetyl-L-aspartate and N-acetyl-Laspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J. Neurochem. 75, 453–459.

    Article  PubMed  CAS  Google Scholar 

  • Baslow M. H. and Resnik T. R. (1997) Canavan disease: Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. J. Mol. Neurosci. 9(2), 109–126.

    Article  PubMed  CAS  Google Scholar 

  • Baslow M. H., Suckow R., Sapirstein V., and Hungund, B. L. (1999) Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J. Mol. Neurosci. 13(1–2), 47–53.

    Article  PubMed  CAS  Google Scholar 

  • Baslow M. H., Suckow R. F., and Hungund B. L., (2000) Effects of ethanol and of alcohol dehydrogenase inhibitors on the reduction of N-acetylaspartate levels of brain in mice in vivo: A search for substances that may have therapeutic value in the treatment of Canavan disease, an autosomally inherited recessive CNS disease. J. Inher. Metal. Dis. 23(7), 684–692.

    Article  CAS  Google Scholar 

  • Bates T. E., Strangward M., Keelan J., Davey G. P., Munro P. M. G., and Clark J. B. (1996) Inhibition of N-acetylaspartate production: implications for 1 H MRS studies in vivo. NeuroReport 7, 1397–1400.

    Article  PubMed  CAS  Google Scholar 

  • Birnbaum S. M., Levintow L., Kingsley R. B., and Greenstein J. P. (1952) Specificity of amino acid acylases. J. Biol. Chem. 194, 455–462.

    PubMed  CAS  Google Scholar 

  • Brustle O., Jones K. N., Learish R. D., Karram K., Choudhary K., Wiestler O. D., et al. (1999) Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science 285, 754–756.

    Article  PubMed  CAS  Google Scholar 

  • Burlina A. P., Ferrari V., Divry P., Gradowska W., Jakobs C., Bennett M. J., et al. (1999) N-acetyl-aspartylglutamate in Canavan disease: an adverse effector? Eur. J. Pediatr. 158, 406–409.

    Article  PubMed  CAS  Google Scholar 

  • Canavan M. M. (1931) Schilders encephalitis periaxialis diffusa. Report of a case in a child aged sixteen and one-half months. Arch. Neurol. Psychiat. 25, 299–308.

    Google Scholar 

  • Einheber S., Zanazzi G., Ching W., Scherer S., Milner T. A., Peles E., and Salzer J. L. (1997) The axonal membrane protein Caspr, a homologue of Neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J. Cell Biol. 139(6), 1495–1506.

    Article  PubMed  CAS  Google Scholar 

  • Elpeleg O. N. and Shaag A. (1999) The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients. J. Inher. Metab. Dis. 22, 531–534.

    Article  PubMed  CAS  Google Scholar 

  • Faull K. F., Rafie R., Pascoe N., Marsh L., and Pfefferbaum A. (1999) N-Acetyl aspartic acid (NAA) and N-acetyl aspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid. Neurochem. Res. 24(10), 1249–1261.

    Article  PubMed  CAS  Google Scholar 

  • Goldstein F. B. (1976) Amidohydrolases of brain; Enzymatic hydrolysis of N-acetyl-l-aspartate and other N-acyl-l-amino acids. J. Neurochem. 26, 45–49.

    Article  PubMed  CAS  Google Scholar 

  • Hagenfeldt L., Bollgren I., and Venizelos N. (1987) N-acetylaspartic aciduria due to aspartoacylase deficiency—a new aetiology of childhood leukodystrophy. J. Inher. Metab. Dis. 10, 135–141.

    Article  PubMed  CAS  Google Scholar 

  • Huang W., Wang H., Kekuda R., Fei Y., Friedrich A., Wang J., et al. (2000) Transport of N-acetylaspartate by Na+-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain. J. Pharmacol. Exp. Therapeut. 295 (1), 392–403.

    CAS  Google Scholar 

  • Kaul R., Casanova J., Johnson A. B., Tang P., and Matalon R. (1991) Purification, characterization, and localization of aspartoacylase from bovine brain. J. Neurochem. 56, 129–135.

    Article  PubMed  CAS  Google Scholar 

  • Kaul R., Gao G. P., Balamurugan K., and Matalon R. (1993) Cloning of the human aspartoacylase cDNA and a common mis-sense mutation in Canavan disease. Nature Genet. 5, 118–123.

    Article  PubMed  CAS  Google Scholar 

  • Kaul R., Gao G. P., Aloya M., Balamurugan K., Petrosky A., Michals K., and Matalon R. (1994) Canavan disease: mutations among Jewish and non-Jewish patients. Am. J. Hum. Genet. 55, 34–41.

    PubMed  CAS  Google Scholar 

  • Kinzley H. (1967) The enzymatic synthesis of N-acetyl-l-aspartic acid by a water-insoluble preparation of a cat brain acetone powder. J. Biol. Chem. 242, 4619–4622.

    Google Scholar 

  • Kvittingen E. A., Guldal G., Borsting S., Skalpe I. O., Stokke O., and Jellum E. (1986) N-Acetylaspartic aciduria in a child with a progressive cerebral atrophy. Clin. Chim. Acta 158, 217–227.

    Article  PubMed  CAS  Google Scholar 

  • Leone P., Janson C. G., McFhee S. J., and During M. J. (1999) Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease. Curr. Opin. Mol. Therap. 1(4), 487–492.

    CAS  Google Scholar 

  • Matalon R. (1997) Canavan disease: diagnosis and molecular analysis. Genet. Testing 1(1), 21–25.

    CAS  Google Scholar 

  • Matalon R., Michals K., Sebasta D., Deanching M., Gashkoff P., and Casanova J. (1988) Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am. J. Med. Genet. 29, 463–471.

    Article  PubMed  CAS  Google Scholar 

  • Matalon R. and Michals-Matalon K. (1999a) Biochemistry and molecular biology of Canavan disease. Neurochem. Res. 24(4), 507–513.

    Article  PubMed  CAS  Google Scholar 

  • Matalon R. and Michals-Matalon K. (1999b) Recent advances in Canavan disease. Adv. Pediatr. 46, 493–506.

    PubMed  CAS  Google Scholar 

  • Mehta V. and Namboodiri M. A. A. (1995) N-Acetylaspartate as an acetyl source in the nervous system. Mol. Brain Res. 31, 151–157.

    Article  PubMed  CAS  Google Scholar 

  • Sager T. N., Fink-Jensen A., and Hansen A. J. (1997) Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia. J. Neurochem. 68, 675–682.

    Article  PubMed  CAS  Google Scholar 

  • Sager T. N., Thomsen C., Valsborg J. S., Laursen H., and Hansen A. J. (1999) Astroglia contain a specific transport mechanism for N-acetyl-l-aspartate. J. Neurochem. 73, 807–811.

    Article  PubMed  CAS  Google Scholar 

  • Shinar Y., Solomon S., Brenner T., McMorris F. A., Yatziv S., and Barash V. (1995) Aspartoacylase activity in rat glial cultures: correlation with 2′,3′-cyclic nucleotide 3′-phosphodiesterase activity. J. Neurochem. 64 (suppl.), S 12 C.

    Google Scholar 

  • Sugahara K., Jianying Z., and Kodama H. (1994) Liquid chromatographic-mass spectrometric analysis of N-acetylamino acids in human urine. J. Chromatog. B 657, 15–21.

    Google Scholar 

  • Tallan H. H., Moore S., and Stein W. H. (1956) N-Acetyl-l-aspartic acid in brain. J. Biol. Chem. 224, 41–45.

    Google Scholar 

  • Taylor D. L., Davies S. E. C., Obrenovitch T. P., Urenjak J., Richards D. A., Clark J. B., and Symon L. (1994) Extracellular N-acetylaspartate in the rat brain. In vivo determination of basal levels and changes evoked by high K+. J. Neurochem. 62, 2349–2355.

    Article  PubMed  CAS  Google Scholar 

  • Traeger E. C. and Rapin I. (1998) The clinical course of Canavan disease. Pediatr. Neurol. 18, 207–212.

    Article  PubMed  CAS  Google Scholar 

  • Wolman M. (1958) The spongy type of diffuse sclerosis. Brain 81, 243–247.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nathan S. Kline Institute for Psychiatric Research, Center for Neurochemistry, 140 Old Orangeburg Road, 10962, Orangeburg, NY

    Morris H. Baslow

Authors
  1. Morris H. Baslow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Morris H. Baslow.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baslow, M.H. Canavan’s spongiform leukodystrophy. J Mol Neurosci 15, 61–69 (2000). https://doi.org/10.1385/JMN:15:2:61

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:15:2:61

Index Entries

Search

Navigation